School of Medicine
Showing 201-250 of 715 Results
-
Mary Hawn, MD, FACS
Emile Holman Professor of Surgery
Current Research and Scholarly InterestsMy area of research is health services researcher focusing on surgical quality measurement and policy. I have a background and training in epidemiology coupled with my leadership roles in surgical quality measurement. My expertise and extensive experience in evaluation of surgical quality process and outcome linkage has impacted national policy and changed guidelines. We performed a comprehensive evaluation of the Surgical Care Improvement Project (SCIP) implementation using national VA data. Defining robust metrics of surgical quality that are actionable and can lead to sustained improvement in our field are of utmost importance. I also have experience with risk prediction modeling for surgical patients. Our Decision Support for Safer Surgery study developed models of real-time risk prediction for major complications and prospectively validated our models in patients and with expert surgeons. We were able to discern where computational risk prediction has added value and where it falls short. We currently have a national study investigating readmissions following major surgical procedures to identify opportunities for improving care and reducing costs.
-
Melanie Hayden Gephart
Professor of Neurosurgery and, by courtesy, of Neurology and Neurological Sciences
BioI am a brain tumor neurosurgeon, treating patients with malignant and benign tumors, including gliomas, brain metastases, meningiomas, and schwannomas. I direct the Stanford Brain Tumor Center and the Stanford Brain Metastasis Consortium, collaborative unions of physicians and scientists looking to improve our understanding and treatment of brain tumors. My laboratory seeks greater understanding of the mechanisms driving tumorigenesis and disease progression in malignant brain tumors. We study how rare cancer cell populations survive and migrate in the brain, inadvertently supported by native brain cells. We develop novel cerebrospinal fluid-based biomarkers to track brain cancer treatment response, relapse, and neurotoxicity. Our bedside-to-bench-to-bedside research model builds on a foundation of generously donated patient samples, where we test mechanisms of brain cancer growth, develop novel pre-clinical models that reliably recapitulate the human disease, and facilitate clinical trials of new treatments for patients with brain cancer.
www.GephartLab.com
www.GBMseq.org
https://stan.md/BrainMets
@HaydenGephartMD -
Cellas Ari'ka Hayes
Postdoctoral Scholar, Epidemiology
BioCellas is currently a postdoctoral fellow/Propel scholar at Stanford University in the Department of Neurology and Neurological Sciences in a laboratory utilizing longitudinal data analysis and neuroimaging modalities to understand the aging brain, neuropathology, cognition, and Alzheimer’s Disease. Postdoctoral experience includes using R, Linux, and Python to perform data preprocessing, multivariate statistical analysis, and applying novel models for longitudinal continuous outcomes. Cellas received his Bachelor’s in Biology (2015-2019) and Doctor of Philosophy in Pharmaceutical Sciences with an emphasis in Pharmacology (2019-2022) from the University of Mississippi. As a doctoral candidate, his research focused on using both in vitro and in vivo approaches to further elucidate how neuroendocrine modulation specifically insulin-like growth factor-1 alters learning and memory performance along with ischemic stroke outcomes. Skills gained during doctoral training included in vitro cell culture, pharmacological experimental design of both in vitro and in vivo studies, development of transgenic mouse models, a wide array of rodent behavioral paradigms, stereotaxic surgery, photothrombosis, and numerous ex vivo cellular, molecular, and microscopy techniques.
My primary interests lie at the intersection of aging, neurodegenerative disease, and using longitudinal epidemiological data sets to investigate hypotheses. All around neuroscientist seeking sci-comm, industry, and academic opportunities to strengthen skills to become an independent investigator. -
Chris Hayward
Professor of Psychiatry and Behavioral Sciences (General Psychiatry and Psychology-Adult)
Current Research and Scholarly InterestsDr. Hayward's research has focused on risk factors for the onset of adolescent internalizing disorders in adolescent girls and the role of early puberty specifically.
-
Hui "Heather" He, PA-C, MSHS-PA
Affiliate, Surgery - General Surgery
BioHui "Heather" He, PA-C, MSHS-PA is an advanced practice provider who specializes in breast surgery and plastic reconstructive surgery. She completed the Masters in Health Sciences for Physician Assistants Program at the Weill Cornell Graduate School of Medical Sciences. Heather has a special interest in benign and malignant conditions of the breast, reconstruction after ablative treatment, and cancer-related lymphedema management. She finds joy in performing 3D nipple areolar tattoos to empower breast cancer patients to feel whole again.
-
Zihuai He
Assistant Professor (Research) of Neurology and Neurological Sciences (Neurology Research), of Medicine (BMIR) and, by courtesy, of Biomedical Data Science
Current Research and Scholarly InterestsStatistical genetics and other omics to study Alzheimer's disease.
-
Catherine Heaney
Associate Professor (Teaching) of Psychology and of Medicine (Stanford Prevention Research Center)
Current Research and Scholarly InterestsEnhancing our understanding of psychosocial factors at work (occupational stress, social support at work, organizational justice, organizational empowerment) that are associated with health and disease.
Developing effective strategies for enhancing employee resiliency and reducing exposure to psychological and behavioral risk factors at work. -
Alesha Heath
Basic Life Research Scientist, Psych/Public Mental Health & Population Sciences
BioDr. Alesha Heath is a Postdoctoral Scholar at Psychiatry and Behavioral Sciences at Stanford School of Medicine and the MIRECC the VA Palo Alto. She earned her PhD from the University of Western Australia and Sorbonne University.
Dr. Heath's research has been primarily focused on the mechanisms and applications of brain stimulation therapies, in particular repetitive transcranial magnetic stimulation. Her research involves both basic and clinical components with the aim of improving the efficacy of these therapies for the treatment of disorders such as depression and Alzheimer's disease. -
Gregory M. Heestand, MD
Clinical Associate Professor, Medicine - Oncology
BioDr. Heestand is a board-certified medical oncologist with a focus on gastrointestinal cancers, primarily hepatocellular carcinoma, cholangiocarcinoma, and gallbladder cancer. He serves as the medical oncology champion of the Stanford Hepatobiliary Tumor Board, as well as the principal investigator of multiple clinical trials. He collaborates with campus laboratories to help develop new biomarker and treatment technologies. He is the former director of the Stanford Oncology Fellowship Program.
Dr. Heestand and his team take great pride in helping patients and their families face gastrointestinal cancer.
Outside of the clinic, Dr. Heestand enjoys playing the piano, teaching his kids about music, cooking for friends and family, and surfing the internet for interesting things to read. -
Katherine (Heflin) Hefcart
Staff, Department Funds
Resident in Psychiatry and Behavioral Sciences
Wise Facilitator, Vice Provost for Graduate EducationBioAdult Psychiatry Resident, focusing on Community/Public Psychiatry, LGBTQ+ competent care, integrative mental health, and reproductive psychiatry. Attended Stanford undergraduate ('11), Harvard T.H. Chan School of Public Health ('15), Dartmouth Geisel Medical School ('23).
-
Nuriya Ruth Hefron
Training & Technical Assistance Manager, Psych/Public Mental Health & Population Sciences
Current Role at StanfordProgram Manager INSPIRE 360
Expansion of Early Psychosis Care Program -
John P. Hegarty II
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioI am a neuroscientist and Principal Investigator of the Stanford Clinical Neuroscience (CNS) Lab in the Department of Psychiatry and Behavioral Sciences as well as Director of Neuroimaging for the Autism and Developmental Disorders Research Program at Stanford. My innovative research studies clinical aspects of cognitive and behavioral neuroscience, with a special focus on examining the neural circuitry associated with important brain-behavior relationships that may underlie different psychological and psychiatric domains in autistic children, adolescents, and adults. The ultimate goal of this research is to improve our understanding of the development of different cognitive and behavioral skills in order to develop mechanistically driven interventions that will improve precision medicine for mental health. Biologically based diagnosis and treatment are extremely limited for most psychological and psychiatric conditions but also critically needed to increase early identification and improve treatment outcomes, especially for neurodevelopmental disorders in which early intervention is the most beneficial. My early career research has primarily focused on clinical neuroscience using neuroimaging (e.g., MRI & EEG) to examine the effects of different drugs and behavioral interventions on the brain, especially for developing biomarkers for improving treatment planning and monitoring biological changes in response to single dose and clinical trials.
My primary contributions to science thus far fall within these major categories: 1) identifying the neural correlates of individual differences in cognition and behavior, 2) developing new interventions and investigating the neurobiological substrates of response to treatment, 3) examining different factors that contribute to brain development, 4) summarizing and increasing accessibility to autism-related research, and 5) methods development for neuroimaging studies. My earliest research investigated the neurobiology of alexithymia, dyslexia, and stress using structural and functional magnetic resonance imaging to test theories of the mechanisms that contribute to differences in cognition and behavior. My subsequent dissertation research, in which I began to focus on neurodevelopmental disorders, examined the neural correlates of response to beta-blockers in autistic adults and also assessed the contribution of cerebellar circuits to the autism phenotype. During my postdoctoral training, I have developed further skills for working with children in multiple clinical research settings, especially for using advanced neuroimaging approaches to examine important brain-behavior relationships. This includes a recent K99/R00 from the National Institute of Child Health and Human Development (NCT04278898 & NCT05664789) that will assess the neurobiology of restricted and repetitive behaviors in autistic children and examine the efficacy and target engagement of a novel nutritional supplement and investigational drug, N-acetylcysteine (NAC), in the brain. You can find more information about our NAC studies at https://redcap.link/NACandAutism. -
Shireen N. Heidari
Clinical Associate Professor, Medicine - Primary Care and Population Health
BioShireen Heidari, MD is a palliative care and family medicine physician. She works as part of the inpatient palliative care consult team providing symptom management and support for patients and families facing any stage of a serious illness. Dr. Heidari is the program director for the Stanford University Hospice and Palliative Fellowship. She previously served as the clinical lead for the Stanford site of the PERIOP-PC Study, collaborating with the surgical department to evaluate the impact of early palliative care support for patients and family members preparing for major upper gastrointestinal cancer surgery.
Dr. Heidari has written about the importance of human connection and stigma around healthcare workers seeking help for their mental health in The New England Journal of Medicine, The Lancet Respiratory Medicine, and The Intima. She hopes that by sharing her own story, she can continue being part of this conversation as we advocate for culture change in medicine and more sustainable practice.
Before moving to northern California, Dr. Heidari attended medical school at Boston University, completed her residency at UC San Diego where she served as chief resident, followed by palliative fellowship at UCLA. Outside of her clinical and mentorship work, she is likely writing creatively or outside with her husband chasing their dogs. -
Paul Heidenreich, MD
Professor of Medicine (Cardiovascular)
Current Research and Scholarly InterestsMy research interests include
1) The cost-effectiveness of new cardiovascular technologies.
Example: tests to screen asymptomatic patients for left ventricular systolic dysfunction.
2) Interventions to improve the quality of care of patients with heart disease. Examples: include clinical reminders and home monitoring.
3) Outcomes research using existing clinical and administrative datasets.
4) Use of echocardiography to predict prognosis (e.g. diastolic dysfunction).
